主页 / 资源 / 按需随选的网络研讨会 / 上市后临床随访的内容、原因和时间

上市后临床随访的内容、原因和时间

Thu, July 21st
按需随选的网络研讨会

Video Coming Soon

In this upcoming paid webinar in partnership with RAPS, Angela Siebeneck, MSN RN, Director of Regulatory Strategy and Policy at Certara | Synchrogenix will be talking through the expectations set by PMCF for many medical devices. As the expectations for EU MDR become clear, PMCF can still be confusing. Together, we will review what may qualify for PMCF, what is required, and when it is required.

A live Q&A portion with Angela will follow the presentation.

This event is brought to you by the RAPS Ontario Chapter to encourage knowledge sharing and community development. RAC holders may claim 1.0 RAC recertification credit.

Upon the conclusion of this webinar, you will:

  • Describe what PMCF is and what is expected.
  • Learn the types of PMCF for different classes of products.
  • Learn how PMCF fits into your regulatory cycle.

Angela Siebeneck, MSN RN
Director of Regulatory Strategy and Policy at Certara | Synchrogenix

Siebeneck 女士拥有超过 30 年的临床和设备经验。她已经为 100 多份针对各种设备的临床评估报告撰写并提供了指导和建议。在她作为护士的职业生涯中,她在开发和实施临床评估策略的许多类型的设备上获得了丰富的实践经验。她甚至还写了一本关于外周导入中心静脉置管 (PICC) 的著作,书中提供了关于如何插入和维护 PICC 的详细信息,并确保遵守使用建议。

返回顶部

沪公网安备 31010102007374 号

Powered by Translations.com GlobalLink OneLink Software